Accept Cookies?
Provided by OpenGlobal E-commerce

Please wait while your page loads ...


Jen Farmer

This email address is being protected from spambots. You need JavaScript enabled to view it.

Chief Executive Officer

Title Created Date Category
Cytokine therapy-mediated neuroprotection in a Friedreich's ataxia mouse model Monday, January 9, 2017 Scientific News
Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich Ataxia Monday, January 9, 2017 Scientific News
Mitochondrial capacity, muscle endurance & low energy in friedreich ataxia Monday, January 9, 2017 Scientific News
Cohort 9, MOXIe, Phase 2 Study of RTA 408 Wednesday, January 4, 2017 Clinical Trials - Completed
A Study of the Safety and Effectiveness of (+) Epicatechin for Treating Patients with Friedreich's Ataxia Thursday, December 29, 2016 Clinical Trials - Completed
Liver Growth Factor (LGF) Upregulates Frataxin Protein Expression and Reduces Oxidative Stress in Friedreich's Ataxia Transgenic Mice Wednesday, December 14, 2016 Scientific News
Horizon Pharma plc Announces Topline Results from Phase 3 Study of ACTIMMUNE® (interferon gamma-1b) in Friedreich's Ataxia Thursday, December 8, 2016 Scientific News
Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals Saturday, December 3, 2016 Funded Research
Challenges ahead for trials in Friedreich's ataxia Wednesday, November 16, 2016 Funded Research
Disruption of Higher Order DNA Structures in Friedreich's Ataxia (GAA)n Repeats by PNA or LNA Targeting Wednesday, November 16, 2016 Scientific News


Event G.jpg
Site Map     Privacy Policy      Service Terms      Contact      Charity Navigator